Treatment related adverse events in children with attention-deficit/hyperactivity disorder using atomoxetine
dc.authorid | 0000-0001-5207-6240 | en_US |
dc.contributor.author | Kasar, Nurdan | |
dc.contributor.author | Yektaş, Çiğdem | |
dc.contributor.author | Tufan, Ali Evren | |
dc.date.accessioned | 2023-06-14T12:32:30Z | |
dc.date.available | 2023-06-14T12:32:30Z | |
dc.date.issued | 2021 | en_US |
dc.department | BAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | Objective: The aim of our study is to evaluate treatment related adverse events in children with attention-deficit/hyperactivity disorder (ADHD) using atomoxetine. Material and Methods: One hundred eleven patients receiving atomoxetine treatment were included in this study. Evaluations were conducted with all participants and their parents using Turgay DSM-IV-Based Child and Adolescent Behavioral Disorders Screening and Rating Scale, Clinic Global Impression Scale and Atomoxetine Side Effect List. Results: Decreased appetite, irritability, loss of weight, fatigue, abdominal pain, constipation, change in sleep patterns, dizziness were common adverse effects of atomoxetine in our study. Diarrhea, rash and skin picking were rare. Changes in sleep patterns were more frequent in patients with the inattentive subtype (chi 2= 5.7, p=0.06, Cramer's V=0.25, Likelihood ratio). Patients using atomoxetine as the only treatment had constipation significantly more frequently than those receiving multiple regimens (p=0.02). Conclusion: Atomoxetine is generally safe and well tolerated. Further studies with a larger sample size are required to investigate adverse effects of atomoxetine treatment. | en_US |
dc.identifier.citation | Kasar, N., Yektas, C., & Ali, E. T. (2021). Treatment Related Adverse Events In Children With Attention-Deficit/Hyperactivity Disorder Using Atomoxetine. Psychiatry and Behavioral Sciences, 11(4), 243. | en_US |
dc.identifier.doi | 10.5455/PBS.20210419035444 | |
dc.identifier.endpage | 248 | en_US |
dc.identifier.issn | 2636-834X | |
dc.identifier.issue | 4 | en_US |
dc.identifier.startpage | 243 | en_US |
dc.identifier.uri | http://dx.doi.org/10.5455/PBS.20210419035444 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12491/11117 | |
dc.identifier.volume | 11 | en_US |
dc.identifier.wos | WOS:000737456900003 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.institutionauthor | Tufan, Ali Evren | |
dc.language.iso | en | en_US |
dc.publisher | YERKURE TANITIM & YAYINCILIK HIZMETLERI A S | en_US |
dc.relation.ispartof | Psychiatry and Behavioral Sciences | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | ADHD | en_US |
dc.subject | Atomoxetine | en_US |
dc.subject | Adverse Events | en_US |
dc.subject | Deficit Hyperactivity Disorder | en_US |
dc.subject | Adolescents | en_US |
dc.title | Treatment related adverse events in children with attention-deficit/hyperactivity disorder using atomoxetine | en_US |
dc.type | Article | en_US |